drug approvals

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

drug approvals
Dec 4, 2024, 06:56 | Insight
Amy K. O’Sullivan: Challenges and Opportunities in Studying Rare Cancers
"In oncology, the shift to biomarker-defined subtypes has important implications for drug development and patient…
Nov 16, 2024, 18:42 | Blog
Paolo Tarantino: Focusing on HR+/HER2- Breast Cancer
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: “HR+/HER2- is the…
Sep 26, 2024, 13:48 | Drugs
Cathy Eng: It's great to see Fruquintinib (FRUZAQLA) approved in Japan for advanced colorectal cancer
Takeda's FRUZAQLA Approved in Japan for Advanced Colorectal Cancer Takeda has secured approval from the…
Jul 19, 2024, 00:31 | Blog
One week to go for the SingHealth Sarcoma Preceptorship 2024
Valerie Yang, Consultant Medical Oncologist at National Cancer Centre Singapore, shared a post on LinkedIn: …
Apr 5, 2024, 08:35 | Insight
Bishal Gyawali: Why 'number of cancer drugs approved' is a poor surrogate for measuring policy success
Alvaro Carrascal, Assistant Professor at University at Albany School of Public Health, shared a post…
Mar 7, 2024, 16:59 | Insight
Vincent Rajkumar: Summary of drug approvals in relapsed myeloma
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic, shared a post on X: “Summary of…
Feb 14, 2024, 06:32 | Insight
Amol Akhade: What is the approach of Indian Oncologist Towards Drug approval agencies?
Amol Akhade, Consultant medical oncologist at Suyog Cancer Clinics, shared on X/Twitter: "What is the…
Feb 4, 2024, 11:19 | Career
Zhiheng Xu: Janet Woodcock is an iconic figure at the FDA
Zhiheng Xu, Lead Mathematical Statistician at CDER, FDA, shared on LinkedIn: "Janet Woodcock is an iconic…
Dec 30, 2023, 04:09 | Drugs
Spencer Knight: Here’s the current 34 approval breakdown by therapeutic area
Spencer Knight, Senior Business Consultant of Cell and Gene Therapy at Charlton Morris, shared on…
All: 9 Posts: 1 - 100
Special Coverage